News （Oct 12, 2019）:The President of H&J CRO International, Dr. Philip MENG addressed to all the colleagues declaring that H&J, after 6 months, 4 round bidding process with other 11 top China CRO competitors, H&J has successfully won the bide of a   35.5Million USD Oncology Project.

It is the biggest Phase III oncology clinical trial in China at present.